Neutral
The Oncology Institute, Inc. (TOI) will hold a virtual annual stockholder meeting on June 17, 2026, where shareholders will vote on the election of ei...
Neutral
Jeffrey Langsam, Chief Clinical Officer of Oncology Institute (NASDAQ: TOI), filed a Form 4 indicating his executive status but reported no stock tran...
Oncology Institute (TOI) Chief Administrative Officer Kristin England has filed a Form 4, indicating no insider trades during the reported period. The...
Bullish
Jorey Chernett, a ten percent owner of Oncology Institute, Inc. (NASDAQ:TOI), purchased 20,000 shares of the company's common stock for $62,000. This ...